19:50 EST Bio-Path Holdings trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BPTH:
- Bio-Path announces 1-for-20 reverse stock split
- Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
- Bio-Path Holdings Approves Reverse Stock Split Vote
- Bio-Path completes first dose escalation part of Phase 1 trial of BP1002
- Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients